(Total Views: 157)
Posted On: 08/16/2024 3:58:02 PM
Post# of 170
NetworkNewsBreaks – HealthLynked Corp. (HLYK) Announces Q2, H1 2024 Financial Results Reflecting Efforts to Streamline Operations
HealthLynked (OTCQB: HLYK), a trailblazer in healthcare technology, today announced financial results for its Q2 and H1 2024 ending June 30, 2024. The announcement noted that the company achieved significant cost reductions, leading to an 8% quarter-over-quarter improvement in its loss from operations to $1.08 million in Q2 2024 from $1.18 million in Q1 2024. This improvement reflects HealthLynked’s ongoing efforts to streamline operations and transition its revenue streams from legacy clinical operations to app-based services. In addition, the company reported revenue of $0.78 million in Q2 2024 and $1.80 million in H1 2024. Its total operating expenses decreased by 25% in Q2 2024 compared to Q2 2023 and by 24% in H1 2024 compared to H1 2023. The net loss was $1.54 million in Q2 2024 and $2.93 million in H1 2024.
“Our continued focus on cost reduction has been crucial in setting a strong foundation for our transition towards app-based technology services. Additionally, our recent partnerships, which have expanded our telemedicine services nationwide and introduced prescription discounts through RxSpark, are pivotal steps in enhancing our offerings. We believe that these strategic initiatives will unlock significant growth opportunities and lead to better healthcare outcomes for our members.”
NOTE TO INVESTORS: The latest news and updates relating to HealthLynked are available in the company’s newsroom at https://nnw.fm/HLYK
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or republished: http://NNW.fm/Disclaimer
HealthLynked (OTCQB: HLYK), a trailblazer in healthcare technology, today announced financial results for its Q2 and H1 2024 ending June 30, 2024. The announcement noted that the company achieved significant cost reductions, leading to an 8% quarter-over-quarter improvement in its loss from operations to $1.08 million in Q2 2024 from $1.18 million in Q1 2024. This improvement reflects HealthLynked’s ongoing efforts to streamline operations and transition its revenue streams from legacy clinical operations to app-based services. In addition, the company reported revenue of $0.78 million in Q2 2024 and $1.80 million in H1 2024. Its total operating expenses decreased by 25% in Q2 2024 compared to Q2 2023 and by 24% in H1 2024 compared to H1 2023. The net loss was $1.54 million in Q2 2024 and $2.93 million in H1 2024.
“Our continued focus on cost reduction has been crucial in setting a strong foundation for our transition towards app-based technology services. Additionally, our recent partnerships, which have expanded our telemedicine services nationwide and introduced prescription discounts through RxSpark, are pivotal steps in enhancing our offerings. We believe that these strategic initiatives will unlock significant growth opportunities and lead to better healthcare outcomes for our members.”
NOTE TO INVESTORS: The latest news and updates relating to HealthLynked are available in the company’s newsroom at https://nnw.fm/HLYK
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or republished: http://NNW.fm/Disclaimer
(0)
(0)
